SCHEMBL5704147

SCHEMBL5704147

C=C[C](C)CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@]1(C)O

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
CYP3A4 P08684 2/20 0.64
CYP2C9 P11712 2/20 0.64
TSHR P16473 2/20 0.64
CYP2C19 P33261 2/20 0.64
MEN1 O00255 1/20 0.64
MAPT P10636 1/20 0.64
KMT2A Q03164 1/20 0.64
TRPV1 Q8NER1 1/20 0.48
TRPA1 O75762 2/20 0.41
PTPN2 P17706 2/20 0.36
PTPN1 P18031 2/20 0.36
CYP19A1 P11511 1/20 0.34
NR1H4 Q96RI1 1/20 0.33
IDO1 P14902 1/20 0.33
PNLIP P16233 1/20 0.33
UGT2B7 P16662 6/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoabienol SCHEMBL20640862 0.86 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL5704327 0.84 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL4780642 0.84 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16984792 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16984810 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16816911 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18949251 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18216691 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16816912 0.83 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL23868641 0.82 ALDH1A1 (0.57) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253909-B1 PHARMACEUTICAL FORMULATIONS COMPRISING LABDANES FOR THE TREATMENT OF TUMORS OR LEUKEMIAS MEDEXIS S A (GR) 2006-09-06 EP disclosed
EP-1253909-A2 PHARMACEUTICAL FORMULATIONS COMPRISING LABDANES FOR THE TREATMENT OF TUMORS OR LEUKEMIAS P.N. GEROLYMATOS S.A. (GR) 2002-11-06 EP disclosed
WO-2001034116-A2 PHARMACEUTICAL FORMULATIONS COMPRISING LABDANES FOR THE TREATMENT OF TUMORS OR LEUKEMIAS P.N. GEROLYMATOS S.A. (GR) 2001-05-17 WO disclosed